Peanut Oral Immunotherapy (OIT) confers long-term tolerance mediated by decreased T-helper Type 2 (TH2) cytokines and cytokines generated by regulatory T cells (Tregs)
Breslin M, Pons L, Yue X, Kulis M, Jones SM, Vickery B, Burks AW. Peanut Oral Immunotherapy (OIT) confers long-term tolerance mediated by decreased T-helper Type 2 (TH2) cytokines and cytokines generated by regulatory T cells (Tregs). J Allergy Clin Immunol. 2010; AB20.